Infant Development clinical trials

Explore recruiting infant development clinical trials.

Recruiting infant development studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Infant Development trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

CeRebrUm and CardIac protection with ALlopurinol in Neonates with Critical Congenital Heart Disease requiring Cardiac Surgery with Cardiopulmonary Bypass

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Tiratricol treatment of children with Monocarboxylate Transporter 8 deficiency: Triac Trial II (MCT8-2019-2)

Czechia, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Effects of closed-loop automatic control of the inspiratory fraction of oxygen (FiO2-C) on outcome of extremely preterm infants – a randomized controlled parallel group multicenter trial for safety and efficacy

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, placebo-controlled, double-blind and double-dummy clinical trial comparing the safety, tolerability, and efficacy of vigabatrin and rapamycin in a preventive treatment of infants with Tuberous Sclerosis Complex

Poland

Phase II and Phase III (Integrated) EU CTIS Study details

Phase I/II safety, tolerability and initial efficacy study of adeno-associated viral vector serotype 9 containing human sulfamidase gene after intracerebroventricular administration to patients with MPSIIIA.

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Infant Development trials by city

Infant Development in Toronto Infant Development in Vancouver Infant Development in Montreal Infant Development in Calgary Infant Development in Edmonton Infant Development in Ottawa Infant Development in Winnipeg Infant Development in Quebec City Infant Development in Hamilton Infant Development in Kitchener Infant Development in London Infant Development in Halifax Infant Development in New York Infant Development in Los Angeles Infant Development in Chicago Infant Development in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease